Photo by tiard from unsplash
The aim of this study was to investigate the outcomes and prognostic factors of patients with metastatic gastrointestinal neuroendocrine tumor (mGI‐NET) who were treated with capecitabine and temozolomide (CAPTEM) and… Click to show full abstract
The aim of this study was to investigate the outcomes and prognostic factors of patients with metastatic gastrointestinal neuroendocrine tumor (mGI‐NET) who were treated with capecitabine and temozolomide (CAPTEM) and somatostatin receptor ligand (octreotide or lanreotide).
Keywords:
temozolomide captem;
gastrointestinal neuroendocrine;
capecitabine temozolomide;
captem effective
Journal Title: Journal of Digestive Diseases
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Digestive Diseases
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!